FDA Inspection 1086932 — Creative Testing Solutions

Creative Testing Solutions — FEI 3000204058

The FDA completed an inspection of Creative Testing Solutions on Mar 21, 2019 in Tempe, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 21, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tempe, AZ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.